Description

Tenginow M Tablet is a medicine that combines the active ingredients Metformin and Teneligliptin. Metformin is an oral antidiabetic medication that helps control blood sugar levels in individuals with type 2 diabetes by reducing glucose production in the liver and improving insulin sensitivity. Teneligliptin, on the other hand, is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases the activity of incretin hormones, aiding in the regulation of blood sugar levels. Tenginow M Tablet is prescribed to individuals with type 2 diabetes to manage their condition effectively. It helps to normalize blood glucose levels by enhancing insulin production and reducing insulin resistance. By combining these two medications, Tenginow M Tablet provides a synergistic effect, enabling better glycemic control and improving overall diabetes management.

Additional information